131 related articles for article (PubMed ID: 10853800)
21. [11C]RN5: a new agent for the in vivo imaging of myocardial alpha1-adrenoceptors.
Matarrese M; Moresco RM; Romeo G; Turolla EA; Simonelli P; Todde S; Belloli S; Carpinelli A; Magni F; Russo F; Galli Kienle M; Fazio F
Eur J Pharmacol; 2002 Oct; 453(2-3):231-8. PubMed ID: 12398909
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow JS; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C
Mol Imaging Biol; 2009; 11(1):23-30. PubMed ID: 18800204
[TBL] [Abstract][Full Text] [Related]
23. Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
Pike VW; Halldin C; Nobuhara K; Hiltunen J; Mulligan RS; Swahn CG; Karlsson P; Olsson H; Hume SP; Hirani E; Whalley J; Pilowsky LS; Larsson S; Schnell PO; Ell PJ; Farde L
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1520-8. PubMed ID: 14579092
[TBL] [Abstract][Full Text] [Related]
24. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
25. Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.
Vasdev N; Natesan S; Galineau L; Garcia A; Stableford WT; McCormick P; Seeman P; Houle S; Wilson AA
Synapse; 2006 Sep; 60(4):314-8. PubMed ID: 16786538
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomography.
Visser TJ; van Waarde A; Doze P; Elsinga PH; van der Mark TW; Kraan J; Ensing K; Vaalburg W
Eur J Pharmacol; 1998 Nov; 361(1):35-41. PubMed ID: 9851539
[TBL] [Abstract][Full Text] [Related]
27. Imaging 5-HT1A receptors with positron emission tomography: initial human studies with [11C]CPC-222.
Houle S; Wilson AA; Inaba T; Fisher N; DaSilva JN
Nucl Med Commun; 1997 Dec; 18(12):1130-4. PubMed ID: 9481759
[TBL] [Abstract][Full Text] [Related]
28. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
Sobrio F; Quentin T; Dhilly M; Bourdier T; Tymciu S; Debruyne D; Barré L
Nucl Med Biol; 2008 Apr; 35(3):377-85. PubMed ID: 18355694
[TBL] [Abstract][Full Text] [Related]
29. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.
Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM
Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117
[TBL] [Abstract][Full Text] [Related]
30. Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies.
Pomper MG; Musachio JL; Scheffel U; Macdonald JE; McCarthy DJ; Reif DW; Villemagne VL; Yokoi F; Dannals RF; Wong DF
J Nucl Med; 2000 Aug; 41(8):1417-25. PubMed ID: 10945536
[TBL] [Abstract][Full Text] [Related]
31. [N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans.
Marthi K; Jakobsen S; Bender D; Hansen SB; Smith SB; Hermansen F; Rosenberg R; Smith DF
Psychopharmacology (Berl); 2004 Jul; 174(2):260-5. PubMed ID: 14726991
[TBL] [Abstract][Full Text] [Related]
32. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice.
Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM
Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544
[TBL] [Abstract][Full Text] [Related]
33. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
[TBL] [Abstract][Full Text] [Related]
34. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biodistribution of the alpha 2-adrenergic receptor antagonist (11C)WY26703. Use as a radioligand for positron emission tomography.
Pleus RC; Shiue CY; Shiue GG; Rysavy JA; Huang H; Cornish KG; Sunderland JJ; Bylund DB
Receptor; 1992; 2(4):241-52. PubMed ID: 1363726
[TBL] [Abstract][Full Text] [Related]
36. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
[TBL] [Abstract][Full Text] [Related]
37. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
Asselin MC; Montgomery AJ; Grasby PM; Hume SP
J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
39. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P
Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
